Spirulina and Glucocorticoid Receptor Signalling: GR, HPA Axis, and Anti-Inflammatory Mimicry

HPA Axis: CRH-ACTH-Cortisol

The hypothalamic-pituitary-adrenal (HPA) axis responds to stress: CRH (corticotropin-releasing hormone) from paraventricular nucleus drives ACTH (adrenocorticotropic hormone) from anterior pituitary corticotrophs. ACTH binds MC2R on adrenal zona fasciculata cells, activating cAMP/PKA/StAR (steroidogenic acute regulatory protein) to mobilise cholesterol for cortisol biosynthesis. Cortisol (hydrocortisone) is the primary human glucocorticoid; corticosterone in rodents. Elevated chronic cortisol causes Cushing syndrome: hyperglycaemia, muscle wasting, and immune suppression. NF-kB activation by pathogens drives CRH/ACTH/cortisol as a counter-regulatory anti-inflammatory signal.

Glucocorticoid Receptor: Structure and Activation

The glucocorticoid receptor (GR/NR3C1) is a ligand-activated nuclear receptor maintained in the cytoplasm by HSP90-HSP70-p23 complex (in inactive conformation). Cortisol binding releases GR from the chaperone complex, exposes the nuclear localisation signal, and drives rapid nuclear translocation. In the nucleus, GR can: (1) Transactivate (homodimer binding to GRE palindromes: nGTACAnnnTGTACn) inducing anti-inflammatory genes (DUSP1/MKP-1, IkBa, glucocorticoid-induced leucine zipper GILZ/TSC22D3, secretory leukocyte protease inhibitor SLPI, lipocortin-1/annexin A1); (2) Transrepress by tethering to NF-kB/p65 or AP-1/c-Jun, blocking their transcription without DNA binding (explaining anti-inflammatory steroid effects).

GR-Driven DUSP1 Induction: Shared Endpoint with Spirulina

DUSP1/MKP-1 is a primary glucocorticoid anti-inflammatory gene: GR transactivates DUSP1 via GRE in its promoter, terminating JNK/p38 stress kinase signalling. This is mechanistically identical to the spirulina-Nrf2-ARE-DUSP1 axis described separately. The convergent induction of DUSP1 by both GR and Nrf2 means spirulina's anti-inflammatory effects partially phenocopy glucocorticoid effects on the MAPK-termination arm, without cortisol's side effects (HPA suppression, insulin resistance, osteoporosis, immunosuppression).

GR Transrepression of NF-kB: IkBa and Direct Tethering

Dexamethasone-activated GR suppresses NF-kB by: (1) inducing IkBa transcription (NF-kB self-limiting loop amplified by GR); (2) physical tethering to p65 (GR LBD/DBD interactions prevent p65 DNA binding); (3) recruiting GRIP1 as a transcriptional repressor to NF-kB target genes. These are the same endpoints that PCB achieves via IKKbeta inhibition and Nrf2-HO-1-CO-NF-kB suppression. The mechanistic overlap validates the observed anti-inflammatory potency of spirulina components in comparison to clinical doses of corticosteroids in some preclinical models.

GILZ (TSC22D3): Anti-Inflammatory Mediator

Glucocorticoid-induced leucine zipper (GILZ/TSC22D3) is a GR-transactivated gene that directly binds and inhibits NF-kB p65 and AP-1 c-Fos/c-Jun, independently of IkBa. GILZ also interacts with PI3K/Akt to suppress mTORC1. GILZ knockout mice show exaggerated LPS-induced inflammatory responses. While GILZ is not an Nrf2 target, the fact that spirulina reduces cortisol-driven HPA activation (by reducing NF-kB- driven inflammatory stress that normally stimulates the HPA axis) may preserve endogenous GILZ levels by maintaining appropriate cortisol pulsatility.

Glucocorticoid Side Effects and the Spirulina Contrast

Prolonged glucocorticoid therapy causes: HPA axis suppression (hypothalamic-pituitary atrophy), insulin resistance (GR-PEPCK induction, glycogenolysis), muscle wasting (GR-FOXO-atrogin-1/MuRF1 ubiquitin ligases), osteoporosis (GR-RANKL, suppressed osteoblasts), and cataracts. Spirulina's shared anti-inflammatory endpoint (DUSP1/NF-kB suppression) with glucocorticoids occurs through NRF2 and AMPK, preserving insulin signalling (AMPK-IRS-1), muscle anabolism, and bone health (no GR atrogin-1 induction), providing a favourable mechanistic contrast.